Cytosorbents Corp 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of the 2023 Annual Meeting of Stockholders held on June 6, 2023. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Princeton, New Jersey. The report covers the voting outcomes for director elections, executive compensation, and auditor ratification.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is a corporate governance report focused on shareholder voting results.
Material Changes and Voting Results
At the record date of April 13, 2023, there were 43,954,198 shares of Common Stock outstanding. A quorum was established with 29,827,126 shares represented. All three proposals submitted to stockholders were approved:
- Proposal 1 (Election of Directors): All five nominees were elected. Notable voting patterns included significant "Against" votes for Michael Bator (2,200,221 votes) compared to other nominees who received between 554,746 and 790,050 "Against" votes. Broker non-votes totaled 8,925,916 for all director nominees.
- Proposal 2 (Executive Compensation): The advisory vote on named executive officer compensation was approved with 14,146,730 "For" votes, 2,774,611 "Against" votes, and 3,979,869 "Abstain" votes.
- Proposal 3 (Auditor Ratification): The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified with 29,413,721 "For" votes, 268,190 "Against" votes, and 145,215 "Abstain" votes.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results. No unusual items or contingencies were reported in this document.
Key Facts for Investor Verification
- Verify the specific reasons for the elevated "Against" votes for director nominee Michael Bator compared to other board members.
- Confirm the total number of shares outstanding and the percentage of shares represented at the meeting to assess shareholder engagement levels.
- Review the full proxy statement for details on the executive compensation package that received advisory approval.
- Note that the independent auditor, WithumSmith+Brown, PC, was ratified for the fiscal year ending December 31, 2023.